Pinnacle Wealth Planning Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Buy
1,637
+20
+1% +$4.38K 0.04% 276
2026
Q1
$306K Sell
1,617
-64
-4% -$11.2K 0.03% 331
2025
Q4
$286K Hold
1,681
0.03% 344
2025
Q3
$222K Buy
+1,681
New +$202K 0.03% 415
2021
Q1
Sell
-25
Closed -$4K 1154
2020
Q4
$4K Buy
+25
New +$3.72K ﹤0.01% 1731

Other funds holding JAZZ

Pinnacle Wealth Planning Services's JAZZ Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Jazz Pharmaceuticals (JAZZ) stake by 1.2% in Q2 2026, buying an estimated $4.38K and bringing the position to 1,637 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #276.

Pinnacle Wealth Planning Services first reported a position in JAZZ in Q4 2020 and has held it in 5 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Pinnacle Wealth Planning Services held 1,637 shares of Jazz Pharmaceuticals worth $394K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 20 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.38K.
  • Jazz Pharmaceuticals made up 0.04% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #276 holding.
  • Pinnacle Wealth Planning Services first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.